The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry (Q39491188)

12 September 2017

The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry (English)

1 reference

12 September 2017

1 reference

1 reference

0 references

1 reference

Che C Colpitts

3

0 references

Philip Meuleman

object named as

Philip Meuleman

10

0 references

Eike Steinmann

object named as

Eike Steinmann

12

0 references

Sandra Ciesek

1

object named as

Sandra Ciesek

1 reference

12 September 2017

7

Michael P Manns

1 reference

12 September 2017

9

Heiner Wedemeyer

1 reference

12 September 2017

5

Martina Friesland

1 reference

12 September 2017

2

Thomas von Hahn

1 reference

12 September 2017

4

Luis M Schang

1 reference

12 September 2017

6

Jörg Steinmann

1 reference

12 September 2017

Michael Ott

8

1 reference

PubMed ID

21837753

12 September 2017

Thomas Pietschmann

11

1 reference

PubMed ID

21837753

12 September 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

12 September 2017

1 reference

12 September 2017

54

1 reference

12 September 2017

1947-1955

1 reference

12 September 2017

6

1 reference

Global epidemiology of hepatitis C virus infection

12 September 2017

1 reference

Hepatitis in 2010: the dawn of a new era in HCV therapy

21 January 2018

1 reference

Retransplantation in patients with hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

Glucocorticosteroids increase cell entry by hepatitis C virus

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

21 January 2018

1 reference

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

21 January 2018

1 reference

Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).

21 January 2018

1 reference

Inhibition of adenovirus infection and adenain by green tea catechins

21 January 2018

1 reference

Antiviral effect of catechins in green tea on influenza virus

21 January 2018

1 reference

Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus

21 January 2018

1 reference

Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line

21 January 2018

1 reference

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

21 January 2018

1 reference

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

21 January 2018

1 reference

Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles

21 January 2018

1 reference

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

21 January 2018

1 reference

A novel small molecule inhibitor of hepatitis C virus entry

21 January 2018

1 reference

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

21 January 2018

1 reference

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

21 January 2018

1 reference

Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies

21 January 2018

1 reference

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

21 January 2018

1 reference

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

21 January 2018

1 reference

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

21 January 2018

1 reference

Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/HEP.24610

1 reference

12 September 2017

1 reference

PubMed ID

21837753